Journals By Industry - Drug Efficacy

In SHARP, VYTORIN 10/20 mg lowered LDL cholesterol in patients with moderate to severe chronic kidney disease, or CKD, and major vascular events were reduced in the treatment group compared to placebo. The...

Keppra was previously approved in the US as adjunctive therapy for partial onset seizures in adults and children four years of age and older with epilepsy. The approval was based on data from...

Results from the trial, expected in 2014, could potentially impact atrial fibrillation treatment guidelines by providing further clinical evidence regarding the benefits of the Arctic Front system in treating a largely underserved patient...

GS-7340 is a novel prodrug of tenofovir, the active agent in Viread, or tenofovir disoproxil fumarate. In previous studies, GS-7340 has demonstrated the ability to provide greater antiviral efficacy at a dose that...

PRINCETON, N.J. & WILMINGTON, Del. -- Bristol-Myers Squibb Company (NYSE: BMY) and AstraZeneca (NYSE: AZN) today announced that the U.S. Food and Drug Administration (FDA) has issued a complete response letter regarding the...

- Additional End-of-Phase 2 Meeting Not Required- -Company to Submit for Special Protocol Assessment- KNOXVILLE, Tenn. -- Provectus Pharmaceuticals, Inc. (OTCBB: PVCT, http://www.pvct.com), a development-stage oncology and dermatology biopharmaceutical company, has received guidance...

DUBLIN -- Research and Markets (http://www.researchandmarkets.com/research/1864b5/key_companies_neu) has announced the addition of the "Key Companies: Neuropathic Pain - In-house to in-license as Big Pharma cuts down on early-stage research" report to their offering. Pfizer...

DUBLIN -- Research and Markets (http://www.researchandmarkets.com/research/7f646b/novolog_type_2_di) has announced the addition of GlobalData 's new report "NovoLog (Type 2 Diabetes) - Analysis and Forecasts to 2020" to their offering. GlobalData's pharmaceuticals report, NovoLog (Type...

KIRKLAND, Wash. -- Vioguard[TM] LLC (www.vioguard.com) today announced it has signed a sales and distribution agreement with HP to market and sell the Vioguard self-sanitizing computer keyboard. The product was recently cleared by...

XenoPort to Receive $10 Million Milestone Payment TOKYO & SANTA CLARA, Calif. -- Astellas Pharma Inc. (Tokyo:4503) and XenoPort, Inc. (NASDAQ:XNPT) announced today that Regnite([R] ) (gabapentin enacarbil) has received marketing approval in...

DUBLIN -- Research and Markets (http://www.researchandmarkets.com/research/42dee7/product_profiles) has announced the addition of the "Product Profiles: Asthma/COPD - Novel Combinations Edge Closer to Market" report to their offering. Despite a number of well-established therapies, the...

BRIDGEWATER, N.J. -- NovaDel Pharma Inc. (OTCBB: NVDL), a specialty pharmaceutical company that develops oral spray formulations of marketed pharmaceutical products, today announced that, as previously disclosed, it is continuing to explore various...

LOS ANGELES -- ImmunoCellular Therapeutics, Ltd. ("ImmunoCellular" or the "Company") (OTCBB: IMUC.OB), an emerging biotechnology company focused on developing novel-immune-based therapies, today announced that its President and CEO, Manish Singh Ph.D., will present...

BERLIN -- JPT Peptide Technologies GmbH (JPT), a wholly-owned subsidiary of BioNTech AG (Mainz, Germany), IUCT and LEITAT (Barcelona, Spain) announced today their collaboration on the joint development of an enhanced anticancer therapy...

New breathable energy product now available for purchase in retail outlets in Boston and New York CAMBRIDGE, Mass. -- Breathable Foods announces the official launch of AeroShot Pure Energy in Boston and New...

PHOENIX -- Administrative burdens and limits on reimbursement are among the obstacles keeping hospitals from choosing to implement potentially lifesaving telemedicine programs, according to a study published in the January/February issue of Telemedicine...

EMERYVILLE, Calif. -- KineMed, Inc. (www.kinemed.com) announced today that co-founders Marc Hellerstein M.D., Ph.D., Chairman of the Scientific Advisory Board of KineMed and David Fineman, KineMed's CEO, will present at the 2012 Personalized...

NEW YORK & PETACH TIKVAH -- BrainStorm Cell Therapeutics Inc. (OTCBB: BCLI), an innovative developer of adult stem cell technologies and Central Nervous System (CNS) therapeutics, today announced that the data from the...

DUBLIN -- Research and Markets (http://www.researchandmarkets.com/research/a21943/pagets_disease_of) has announced the addition of GlobalData 's new report "Paget's Disease of Bone (PDB) Therapeutics - Pipeline Assessment and Market Forecasts to 2018" to their offering. PDB...